Owens & Minor, Inc. (OMI)
NYSE: OMI · IEX Real-Time Price · USD
24.87
-0.12 (-0.48%)
Apr 16, 2024, 11:43 AM EDT - Market open

Company Description

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.

It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Its portfolio of medical and surgical supplies includes branded products and its proprietary products.

This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers.

The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment.

This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services.

It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors.

Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.

Owens & Minor, Inc.
Owens & Minor logo
Country United States
Founded 1882
Industry Medical Distribution
Sector Healthcare
Employees 22,200
CEO Edward A. Pesicka

Contact Details

Address:
9120 Lockwood Blvd
Mechanicsville, Virginia 23116
United States
Phone (804) 723-7000
Website owens-minor.com

Stock Details

Ticker Symbol OMI
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000075252
CUSIP Number 690732102
ISIN Number US6907321029
Employer ID 54-1701843
SIC Code 5047

Key Executives

Name Position
Edward A. Pesicka President, Chief Executive Officer and Director
Alexander J. Bruni Executive Vice President and Chief Financial Officer
Andrew G. Long Executive Vice President and Chief Executive Officer of Products and Healthcare Services Segment
Daniel J. Starck Executive Vice President of Business Excellence
Perry A. Bernocchi Executive Vice President and Chief Executive Officer of Patient Direct Segment
Michael Wayne Lowry Senior Vice President, Corporate Controller and Chief Accounting Officer
Heath H. Galloway Executive Vice President, General Counsel and Corporate Secretary
Jonathan A. Leon Senior Vice President and Corporate Treasurer
Trudi Allcott Director of Media Relations

Latest SEC Filings

Date Type Title
Mar 27, 2024 ARS Filing
Mar 27, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2024 DEF 14A Other definitive proxy statements
Mar 1, 2024 8-K Current Report
Feb 27, 2024 144 Filing
Feb 20, 2024 10-K Annual Report
Feb 20, 2024 144 Filing
Feb 20, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals